Plasma homocysteine concentration and peripheral neuropathy in Parkinson's disease patients: A pilot study

被引:0
|
作者
Nevrly, M.
Vranova, H.
Chovancova, Z.
Nestrasil, I.
Otruba, P.
Dufek, J.
Kanovsky, P.
机构
关键词
D O I
10.1016/S1353-8020(08)70433-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S49 / S49
页数:1
相关论文
共 50 条
  • [21] Peripheral neuropathy and autonomic dysfunction in patients with Parkinson's disease and parkinsonism
    Gondim, F. d. A. A.
    Oliveira, I. S.
    Araujo, D. F.
    Oliveira, G. R.
    Alves, L. C.
    Melo, A. P.
    Nogueira, G. H.
    Andrade, E. N.
    Goes, W. H.
    MOVEMENT DISORDERS, 2013, 28 : S75 - S75
  • [22] A Case Series of Peripheral Neuropathy in Patients with Parkinson's Disease Reply
    Toth, Cory
    Zochodne, Douglas
    Suchowersky, Oksana
    ANNALS OF NEUROLOGY, 2010, 68 (06) : 975 - 975
  • [23] Peripheral neuropathy in Parkinson's disease: an in vivo confocal microscopy study
    Vieira, L.
    Anjos, R.
    De Sousa, A.
    Silva, N.
    Basilio, A. L.
    Maduro, V. Santos
    Alves, N.
    Candelaria, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 148 - 148
  • [24] Peripheral neuropathy in the Parkinson's disease, a case-control study
    Perez Galdos, P.
    MOVEMENT DISORDERS, 2013, 28 : S261 - S261
  • [25] Effect of levodopa and entacapone treatment on plasma homocysteine level in Parkinson's disease. Pilot study.
    Nevrly, M.
    Ressner, P.
    Nestrasil, I.
    Vranova, H.
    Herzig, R.
    Kanovsky, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 93 - 93
  • [26] Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease
    Isobe, C
    Murata, T
    Sato, C
    Terayama, Y
    LIFE SCIENCES, 2005, 77 (15) : 1836 - 1843
  • [27] Plasma homocysteine and cognitive impairment in Parkinson's disease
    Quinn, J. F.
    Jewell, S.
    Murchison, C.
    Carney, N.
    Lobb, B.
    O'Connor, S.
    Chung, K.
    Zabetian, C.
    Leverenz, J.
    Montine, T.
    Cholerton, B.
    Edwards, K.
    Peterson, A.
    MOVEMENT DISORDERS, 2014, 29 : S360 - S360
  • [28] Elevated plasma levels of homocysteine in Parkinson's disease
    Kuhn, W
    Roebroek, R
    Blom, H
    van Oppenraaij, D
    Przuntek, H
    Kretschmer, A
    Büttner, T
    Woitalla, D
    Müller, T
    EUROPEAN NEUROLOGY, 1998, 40 (04) : 225 - 227
  • [29] Plasma homocysteine and clinical characteristics in Parkinson's disease
    Hassin-Baer, S
    Cohen, O
    Vakil, E
    Nitsan, Z
    Sela, BA
    Tanne, D
    MOVEMENT DISORDERS, 2004, 19 : S162 - S162
  • [30] Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients
    Lamberti, P
    Zoccolella, S
    Iliceto, G
    Armenise, E
    Fraddosio, A
    de Mari, M
    Livrea, P
    MOVEMENT DISORDERS, 2005, 20 (01) : 69 - 72